Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06183073Phase 2Recruiting
Phase 2, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Sohag University. Primary endpoint: 1st analgesic requirement at 12 hours. Started Apr 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06183073.